Effect on the HIV Diagnosis Rates of Integration of AIDS Indicator Conditions Into the Hospital Information Systems
HIV-IC
HIV-IC: Effect on the HIV Diagnosis Rates of Integration of AIDS Defining and Indicator Conditions Into the Hospital Information Systems (HIS): 2 Phase, Multicenter Retrospective Study
1 other identifier
observational
10,000
1 country
1
Brief Summary
to describe the change in the number of HIV diagnosis before and after the integration of the indicator conditions and diseases to hospital automation system
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2022
CompletedFirst Submitted
Initial submission to the registry
December 16, 2022
CompletedFirst Posted
Study publicly available on registry
December 28, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
February 28, 2024
CompletedDecember 28, 2022
December 1, 2022
1.6 years
December 16, 2022
December 23, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Change in the number of HIV diagnosis before and after the integration of the indicator conditions and diseases to hospital automation system
Change in the number of HIV diagnosis before and after the integration of the indicator conditions and diseases to hospital automation system
Through study completion, an average of 18 months
Interventions
Non-interventional
Eligibility Criteria
All patients who apply to hospital to any clinic will be screened
You may qualify if:
- All patients who apply to hospital to any clinic will be screened
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ankara Eğitim ve Araştırma Hastanesi
Ankara, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
ilker kurkcu
Sentez-CRO
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Infectious Diseases Department
Study Record Dates
First Submitted
December 16, 2022
First Posted
December 28, 2022
Study Start
June 1, 2022
Primary Completion
December 30, 2023
Study Completion
February 28, 2024
Last Updated
December 28, 2022
Record last verified: 2022-12
Data Sharing
- IPD Sharing
- Will not share